PRICKLE2 and non-small cell lung carcinoma: In patients with lung adenocarcinoma (LUAD), a subtype of NSCLC, miR-665 can enhance the malignancy of cells by binding to Prickle Planar Cell Polarity Protein 2 (PRICKLE2).